> Markdown version of [/jobs/ext/4747585-lead-scientist-large-molecules](https://www.wearedevelopers.com/jobs/ext/4747585-lead-scientist-large-molecules). Every page supports `.md` or `Accept: text/markdown`. Links point to the HTML versions so they work for humans too. Agent guide: [/agents.md](https://www.wearedevelopers.com/agents.md). --- # Lead Scientist - Large Molecules - **Company:** APHROS, LLC - **Location:** United States - **Experience:** Expert - **Contract:** Permanent contract - **Skills:** Artificial Intelligence, Computer Networks, AlphaFold - **Published:** November 16, 2026 - **Apply:** https://www.careerbuilder.com/job-details/lead-scientist-large-molecules--b9a3569f-e173-4065-b7e0-ccc549e73b15 ## About the Role Antibodies, Biotech and Pharmaceutical, Drug Development, Computer Networks, Artificial Intelligence (AI), Research & Development (R&D), Drug Discovery, Team Lead/Manager, Biology, Small Molecules, * You have a PhD, MSc, or equivalent experience, plus 5+ years in structural biology, antibody engineering, immunology, protein engineering, or a related biologics discipline * You have real hands-on experience in antibody design, developability, or binder discovery - this is a domain-knowledge-first role * You have some exposure to applying AI/ML to biological problems - you don''t need to build models yourself, but you understand them well enough to contribute to a modeling workflow and judge whether outputs make sense * You''re comfortable partnering closely with ML/engineering teams and translating between biological reasoning and technical implementation * You communicate clearly across scientific and technical audiences, and with pharma partner stakeholders Nice to have * You''re familiar with OpenFold, AlphaFold, Boltz, or similar structure prediction tools * You have experience with antibody developability assays, immunogenicity, or biologics manufacturability specifically * You''ve worked directly with pharma partners or in a consortium/collaborative research setting * You have a publication record in structural biology, immunology, or antibody engineering venues ## Description We''re looking for a large molecule specialist to bring deep domain knowledge in antibody engineering, structural biology, and biologics to our networks. You''ll help define the scientific workflows and modeling strategy for antibody-antigen co-folding, binder prediction, and developability prediction - working closely with our ML and engineering team, who own the actual model-building. We need this person to give large molecules a real point of ownership at Apheris: someone who decides what''s scientifically relevant as the network grows, and who partners can trust to speak with genuine drug-discovery credibility, not just AI credibility. You don''t need to write training code or build the models yourself. You do need enough AI/ML fluency to have a real, informed say in what gets built: sanity-checking results, catching where a modeling approach doesn''t reflect biological reality, and helping translate scientific questions into a workable plan. What you will do * Define the scientific workflow, evaluation strategy, and benchmarking approach for our large molecule programs, including antibody-antigen co-folding, binder prediction, and antibody developability * Use our own product as a hands-on user, and define user requirements for large molecule workflows so what gets built actually matches how scientists work * Drive adoption of our large molecule models with pharma partners - helping them identify which programs and use cases they should be applied to, and supporting them in getting real value out of them * Translate scientific and biological requirements from pharma partners into concrete inputs the ML/engineering team can build against * Review model outputs and evaluation results against real structural biology / antibody engineering knowledge, flagging where something doesn''t hold up biologically * Represent Apheris''s scientific perspective in partner conversations across our large molecule networks - aligning on objectives, evaluation criteria, and data requirements * Stay current on the large molecule AI/ML landscape (OpenFold, AlphaFold, Boltz, ESM, antibody design/developability literature) enough to have informed opinions on modeling approach * Work with product, ML, and engineering to make sure scientific requirements genuinely shape the roadmap, not just get bolted on afterward